Compile Data Set for Download or QSAR
Report error Found 18 Enz. Inhib. hit(s) with all data for entry = 12297
TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 1.26nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 1.36nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 1.49nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 1.57nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 1.66nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf [V600E](Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 2.14nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 2.22nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 2.31nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf [V600E](Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 2.43nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 2.95nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 3.49nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf [V600E](Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 3.58nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf [V600E](Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 3.64nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetRAF proto-oncogene serine/threonine-protein kinase(Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 3.74nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 3.77nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf [V600E](Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 4.98nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf(Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 7.41nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetSerine/threonine-protein kinase B-raf [V600E](Human)
Shenzhen Targetrx

US Patent
LigandPNGBDBM221688(US9314464, 9 | US9593100, Compound 9 | US10568884,...)
Affinity DataIC50: 12nMAssay Description:Inhibitory activities of test compounds against BRAF (Invitrogen, PV3848), cRAF (BPS Bioscience, 40008) and BRAF (V600E) (Invitrogen, 40533) were det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent